Interleukin (IL)-1β and IL-17A are important inflammatory cytokines implicated in the pathogenesis of RA, and blockage of these molecules alleviates the severity of CIA in mice (Wu et al., 2016). Here, IL17A is linked to rheumatoid arthritis.